The Monoclonal Antibody Custom Service Market Research provides a deep dive into the technological and strategic shifts shaping the antibody development ecosystem. With the rise of biologics and biosimilars, pharmaceutical companies are outsourcing more stages of the antibody creation process. From hybridoma screening to recombinant cloning, service providers now offer fully customizable...